ANTIBODY OR AN ANTIGEN-BINDING FRAGMENT THEREOF CAPABLE OF BINDING TO A HUMAN RECEPTOR OF INTERLEUKIN-6

The invention relates to medicine. The problem addressed by the present invention consists in creating alternative antibodies or fragments thereof which are capable of specifically binding to a human receptor of interleukin-6 and which would be useful as drugs for treating or diagnosing diseases, or...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ULITIN, ANDREI BORISOVICH, VLADIMIROVA, ANNA KONSTANTINOVNA, CHERNOVSKAYA, TATIANA VENIAMINOVNA, EVDOKIMOV, STANISLAV RUDOLFOVICH, SOLOVYEV, VALERY VLADIMIROVICH, NEMANKIN, TIMOFEY ALEKSANDROVICH, MOSHCHENKO, ALEKSANDR ALEKSANDROVICH, NALOBINA, VIKTORIIA EVGENEVNA, MOROZOV, DMITRY VALENTINOVICH, CHERNYKH, YULIA SERGEEVNA, SMOTROV, OLEG IGOREVICH, ALEKSANDROV, ALEKSEI ALEKSANDROVICH, IVANOV, ROMAN ALEKSEEVICH
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to medicine. The problem addressed by the present invention consists in creating alternative antibodies or fragments thereof which are capable of specifically binding to a human receptor of interleukin-6 and which would be useful as drugs for treating or diagnosing diseases, or for relieving symptoms, mediated by interleukin-6. L'invention concerne la médecine. L'objectif de la présente invention consiste à créer des anticorps alternatifs ou de leurs fragments qui sont aptes à se lier au récepteur d'interleukine-6 de l'humain qui pourraient s'utiliser en tant que médicaments pour traiter ou diagnostiquer les maladies ou atténuer leurs symptômes à médiation par interleukine-6.